PDF-HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include

WARNING DISTANT SPREAD OF TOXIN EFFECT See full prescribing information for complete boxed warning The effects of BOTOXand all botulinum toxin products may spread from the area of injection to produ. See full prescribing information for BIOTHRAX BIOTHRAX Anthrax Vaccine Adsorbed Suspension for Intramuscular or Subcutaneous Injection Initial US Approval 1970 RECENT MAJOR CHANGES DOSAGE AND ADMINISTRATION 21 May2012 INDICATIONS AND USAGE Bacillu See full prescribing information for LATISSE LATISSE bimatoprost ophthalmic solution 003 Initial US Approval 2001 INDICATIONS AND USAGE LATISSE is a prostaglandin analog indicated to treat hypotrichosis of the eyelashes by increasing their growth FULL PRESCRIBING INFORMATION: CONTENTS* INDICATIONS AND USAGE1.1Alzheimer --------------------------RECENT MAJOR CHANGES---------------------------- Boxed Warning 04/15 Indications and Usage (1.1) 04/15 Dosage and Administration (2.1, 2.2) 04/15 Warnings a NDA 22-288/S-003 Reference ID: 3151309 NDA 22-288/S-003 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE BEPREVE (bepotastine besilate ophthalmic solution) 1.5% is a histamine H receptor antagoni Adults and Children 30 kg (66 lbs) or more: 0.3 to 0.5 mg (0.3 to 0.5 mL) intramuscularly or subcutaneously into anterolateral aspect of the thigh every 5 to 10 minutes as necessary (2.1) Children 30 5.1Hypersensitivity5.2Exogenous Ochronosis5.3Effects on Endocrine System5.4Cutaneous ReactionsADVERSE REACTIONSUSE IN SPECIFIC POPULATIONS8.1Pregnancy8.3NursingMothers8.4Pediatric Use8.5Geriatric Use1 WARNING: LOSS OF BONE MINERAL DENSITY Women who use Depo-Provera Contraceptive Injection may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be __________________________________________________________________ FULL PRESCRIBING INFORMATION INDICATIONS AND USAGE Jakafi is indicated for treatment of patients with intermediate or high-risk Reference ID 3406989FULL PRESCRIBING INFORMATION INDICATIONS AND USAGE luliconazole Cream 1 is indicated for the topical treatment of interdigital tinea pedis tinea cruris and tinea corporis caused b FULL PRESCRIBING INFORMATION CONTENTS INDICATIONS AND USAGEDOSAGE AND ADMINISTRATIONDOSAGE FORMS AND STRENGTHSCONTRAINDICATIONSWARNINGS AND PRECAUTIONS5152Nephrotoxicity53Neuromuscular Disorders54Bron Reference ID 4330857FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE TOBI is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudom treatment and adjust dosing as needed 22 51 constipation nausea and vomiting as needed 22 52 Peripheral Neuropathy Monitor patients for symptoms of peripheral neuropathy and adjust dosing as needed 2 Limitations of Use: Due to the possible association between malignancy and calcitoninsalmon use, the need for continued therapy should be reevaluated on a . -------------------------------DRUG INTER